A Clinical Trial To Study The Effect Of Tila Nala Kshara For The Treatment Of Stones Of Urinary System.

"Study Of Efficacy Of Tila Nala Kshara In The Management Of Mutrashmari With Special Reference To Urolithiasis: Randomized Open Labelled Controlled Clinical Trial" - STIM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/027911

Enrollment

Registered

2020-09-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: Tila Nala Kshara: Tila Nala Kshara Route of administration-oral Dose-1gm twice a day Duration -7 days Control Intervention1: Kadali Kshara: Kadali Kshara Route of administration- oral

Eligibility

Inclusion criteria

Inclusion criteria: Patient Of Mutrashmari Of Size Minimum 4mm To Maximum 20mm Patients Of Obstructive As Well As Non Obstructive Pathology With Normal KFT Patients Of Mutrashmari With Renal And/Or Ureteric And/Or UVJ Calculus

Exclusion criteria

Exclusion criteria: Patients Of Obstructive Pathology With Changes Of Severe Hydronephrosis In USG Patient Is Having Uncontrolled Diabetes And/Or Hypertension And/Or Asthma And Other Major Systemic Illness Impaired Renal Function Pregnant And Lactating Mother Urinary Calculi Having Size More Than 20mm Kshara Ayogya Vyadhi

Design outcomes

Primary

Measure	Time frame
To find out how this drug reduces the size of Mutrashmari or promotes its expulsionTimepoint: 7 Days	—

Secondary

Measure	Time frame
To establish the better medicinal alternative in the management of Mutrashmari To find out whether this drug shortens the duration of treatment of Mutrashmari than other drugsTimepoint: 7days	—

Countries

India

Contacts

Public ContactVd Hemant Rohidas Maske

Government Ayurved College and Hospital Nanded

hemantmaske2010@gmail.com9422185884

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026